Breast Cancer is a personal diagnosis, requiring a personal treatment plan. Clinical trials can offer new opportunities for patients facing a breast cancer diagnosis, globally – and but trust between the medical community, industry, clinical trial stakeholders, and under-represented communities – specifically Black and brown ones – must first be rebuilt before a trial is considered, trusted and adhered to.